A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty
Clinical trial NCT06545097 · COMPLETED
Trial details
- NCT number
- NCT06545097
- Sponsor
- Tris Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-03
- Primary completion
- 2024-12-30
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.